Pharma · Private company
Janssen Pharmaceuticals
Track this companyFree. Adds Janssen Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials2521 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Improving Health Literacy in Patients With Schizophrenia Spectrum DisorderNA · NOT_YET_RECRUITING · started Mar 1, 2026ClinicalTrials.gov NCT07488156 · fetched Nov 12, 2026
- Teclistamab-Daratumumab in AL AmyloidosisPHASE2 · RECRUITING · started Nov 7, 2025ClinicalTrials.gov NCT07110844 · fetched Nov 12, 2026
- Biomarkers of AKI in Patients Receiving DaratumumabCOMPLETED · started Sep 1, 2024ClinicalTrials.gov NCT06549634 · fetched Nov 12, 2026
- Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)RECRUITING · started Aug 13, 2024ClinicalTrials.gov NCT06396533 · fetched Nov 12, 2026
- Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell AntibodyPHASE2 · RECRUITING · started Apr 3, 2024ClinicalTrials.gov NCT06358638 · fetched Nov 12, 2026
- Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple MyelomaPHASE2 · RECRUITING · started Dec 21, 2023ClinicalTrials.gov NCT06107738 · fetched Nov 12, 2026
- A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)PHASE2 · RECRUITING · started Oct 16, 2023ClinicalTrials.gov NCT06083922 · fetched Nov 12, 2026
- A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell TherapyPHASE2 · RECRUITING · started Sep 27, 2023ClinicalTrials.gov NCT06066346 · fetched Nov 12, 2026
- TrEatment Approach in the Multimodal Era RegistryACTIVE_NOT_RECRUITING · started Apr 12, 2023ClinicalTrials.gov NCT05629052 · fetched Nov 12, 2026
- Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected AdultsPHASE1_PHASE2 · COMPLETED · started Apr 1, 2022ClinicalTrials.gov NCT04983030 · fetched Nov 12, 2026
- A Study of Amivantamab in People With Esophagogastric CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 2, 2021ClinicalTrials.gov NCT05117931 · fetched Nov 12, 2026
- Tumor Microenvironment Analysis of Prostate Cancer MetastasisRECRUITING · started Sep 15, 2021ClinicalTrials.gov NCT05304858 · fetched Nov 12, 2026
- DARA RVD For High Risk SMMPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 8, 2021ClinicalTrials.gov NCT04775550 · fetched Nov 12, 2026
- A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple MyelomaPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 11, 2020ClinicalTrials.gov NCT04268498 · fetched Nov 12, 2026
- Pan Tumor Rollover StudyPHASE2 · RECRUITING · started Aug 9, 2019ClinicalTrials.gov NCT03899155 · fetched Nov 12, 2026
- Early Check: Expanded Screening in NewbornsACTIVE_NOT_RECRUITING · started Oct 15, 2018ClinicalTrials.gov NCT03655223 · fetched Nov 12, 2026
- A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell TransplantationPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 2, 2018ClinicalTrials.gov NCT03556332 · fetched Nov 12, 2026
- Daratumumab, Ixazomib, and Dexamethasone in AL AmyloidosisPHASE1 · COMPLETED · started Feb 7, 2018ClinicalTrials.gov NCT03283917 · fetched Nov 12, 2026
- Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple MyelomaPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 24, 2017ClinicalTrials.gov NCT03236428 · fetched Nov 12, 2026
- A Study of Daratumumab in Patients With Newly Diagnosed Multiple MyelomaPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 25, 2017ClinicalTrials.gov NCT03290950 · fetched Nov 12, 2026
- Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected AdultsPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 28, 2016ClinicalTrials.gov NCT02951052 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive ParticipantsPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 27, 2016ClinicalTrials.gov NCT02938520 · fetched Nov 12, 2026
- AASUR in High Risk Prostate CancerPHASE2 · COMPLETED · started May 12, 2016ClinicalTrials.gov NCT02772588 · fetched Nov 12, 2026
- Pediatric Pulmonary Hypertension Network (PPHNet) Informatics RegistryRECRUITING · started Oct 1, 2014ClinicalTrials.gov NCT02249923 · fetched Nov 12, 2026
- A Phase I Study of Mebendazole for the Treatment of Pediatric GliomasPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 22, 2013ClinicalTrials.gov NCT01837862 · fetched Nov 12, 2026